The University of Manchester’s approach to cancer research spans the full spectrum of combating the disease.
One in two of us will be diagnosed with some form of cancer during our lifetime. Cancer may be one illness, but there are over 200 types – and a diagnosis affects whole families.
Breadth of our research
The University of Manchester’s medical research ranges from understanding the molecular and cellular basis of cancer to the development and testing of novel drugs and other therapeutic approaches. Through nursing, psychology and policy work, solutions to the physical, emotional and economic impacts of cancer are being researched and put into practice across the University.
Led by world-renowned scientists such as Professor Sir Salvador Moncada and Professor Richard Marais, cancer research at the University has the academic strength to match the weight of our partnerships and the benefits of our location.
Reach and impact
Our links with NHS organisations and cancer charities – as well as the support of the local population – make for an unrivalled beacon of research, where outstanding clinical work is leading to innovative techniques and personalised treatments.
Through the Manchester Cancer Research Centre we work with Cancer Research UK and The Christie NHS Foundation Trust to turn research findings in the laboratory into better, more effective, treatments for cancer patients. The Centre’s new building will house 150 researchers and world-class facilities for imaging and sample analysis.
Our trials led to anastrozole replacing tamoxifen as the major endocrine therapy for breast cancer, a development that has benefited 1.5 million women globally. Our partnerships with companies such as AstraZeneca and GlaxoSmithKline bring new drugs to the market.
And we’re reaching out to where help is needed most – such as in Uganda, where our academics and medics are helping to roll out a national programme of cervical cancer screening.
Cancer is a disease that affects so many, in different, often devastating, ways. At The University of Manchester we want to loosen cancer’s grip and improve the lives of those it affects.
Good indicator of cancer prognosis turned on its head
A molecule that for the last 20 years has been believed to be an indicator of good prognosis in tumours has been shown to have a dark side by new research.
Manchester researchers join forces with 'US moonshot'
A Manchester-US collaboration is set to revolutionise how researchers capture and analyse cancer cells.
£18m lab opens to discover the clues to individuals’ illnesses
The University has opened the Stoller Biomarker Discovery Centre, which will identify the unique markers of diseases such as cancer or arthritis.
Feature: Cancer medicine – the personal approach
Three of our scientists tackling different cancer challenges explain what personalised medicine means to them.
Scientists target 'Achilles heel' of leukaemia
Manchester and Glasgow researchers have found drugs to successfully target an ‘Achilles heel’ of Chronic Myeloid Leukaemia and eradicate the disease in mice.
Institute of Cancer Sciences
The ICS sits in the Faculty of Medical and Human Sciences.
Visit the Institute of Cancer Sciences website.
Manchester Cancer Research Centre
The MCRC was formed in 2006 by the University, CRUK and The Christie NHS Foundation Trust.
Visit the MCRC website
Cancer Research UK Manchester Institute
A leading cancer research institute within the University, core funded by Cancer Research UK.
Visit the CRUK Manchester Institute website
Faculty of Medical and Human Sciences
Explore the breadth of research at our Faculty of Medical and Human Sciences.
Visit the Faculty of Medical and Human Sciences website
Faculty of Life Sciences
Discover the research themes of our Faculty of Life Sciences.
Visit the Faculty of Life Sciences website